New drug shows promise for managing short bowel syndrome long-term
NCT ID NCT03905707
First seen Feb 02, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tests the long-term safety of glepaglutide in people with short bowel syndrome, a condition where the body can't absorb enough nutrients from food. About 145 patients who completed earlier trials are taking part. The goal is to see if the drug is safe over time and helps manage the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asklepios Kliniken Hamburg GmbH
Hamburg, Germany
-
Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
-
Charité - Universitätsmedizin Berlin
Berlin, Germany
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Hôpital Beaujon
Clichy, France
-
Mayo Clinic College of Medicine
Rochester, Minnesota, 55905, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
Rigshospitalet
Copenhagen, Denmark
-
Solumed
Poznan, Poland
-
St Mark's Hospital
Harrow, United Kingdom
-
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Poland
-
The Royal Alexandra Hospital
Edmonton, Canada
-
UCLH Foundation NHS Trust
London, United Kingdom
-
UMC Radboud Nijmegen
Nijmegen, Netherlands
-
UZ Leuven
Leuven, Belgium
-
University Health Network - Toronto General Hospital
Toronto, Canada
-
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom
-
University of Chicago Children's Hospital
Chicago, Illinois, 60637, United States
-
University of East Anglia
Norwich, United Kingdom
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198-3285, United States
-
Universitätsklinikum Bonn
Bonn, 53127, Germany
-
Universitätsklinikum Frankfurt - Med. Klinik I
Frankfurt, Germany
-
Universitätsmedizin Rostock
Rostock, Germany
-
Vanderbilt University Medical Center, Nashville
Nashville, Tennessee, 68198-3285, United States
-
Western University
London, N6A 4V2, Canada
-
Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi
Lodz, Poland
Conditions
Explore the condition pages connected to this study.